Good “Pharming” Practices: FDA Outlines CMCs For Plant-Made Drugs
Executive Summary
Pharmaceuticals derived from bioengineered plants should include a description of harvesting methods in the chemistry, manufacturing & controls section of NDAs and BLAs, a joint FDA/USDA 1draft guidance on plant-made pharmaceuticals says